Published in Proc Natl Acad Sci U S A on September 02, 1997
Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med (2010) 5.84
Cancer stem cells: an evolving concept. Nat Rev Cancer (2012) 4.57
Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol (2010) 3.13
Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest (2003) 2.37
Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood (2011) 2.12
Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest (2000) 2.05
The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med (2000) 2.00
Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest (2000) 1.56
Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. Mol Cell Biol (2003) 1.50
Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol (2009) 1.49
Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest (2001) 1.43
Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A (2002) 1.41
High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J Clin Invest (2004) 1.35
Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc Natl Acad Sci U S A (2002) 1.32
Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med (1998) 1.27
Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J Exp Med (2011) 1.25
Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. Blood (2011) 1.18
Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest (2001) 1.18
Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors. J Exp Med (2002) 1.16
Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype. J Clin Invest (2001) 1.16
The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc Natl Acad Sci U S A (2000) 1.14
Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice. Blood (2013) 1.13
Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin. J Biomed Mater Res A (2006) 1.10
The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J (2001) 1.10
Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice. Exp Biol Med (Maywood) (2008) 1.10
Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest (2012) 1.09
Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. Blood (2010) 0.97
cDNA cloning of FRIL, a lectin from Dolichos lablab, that preserves hematopoietic progenitors in suspension culture. Proc Natl Acad Sci U S A (1999) 0.91
Expansion of haematopoietic stem cells from normal donors and bone marrow failure patients by recombinant hoxb4. Br J Haematol (2008) 0.91
In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis. Haematologica (2014) 0.83
Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion. Stem Cells Int (2011) 0.83
Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science. Biotechnol J (2015) 0.80
Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells. World J Gastroenterol (2006) 0.79
Hematopoietic stem cells. Methods Enzymol (2006) 0.78
Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene. Leukemia (2012) 0.78
Distinct signaling programs control human hematopoietic stem cell survival and proliferation. Blood (2016) 0.77
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function. Blood (2006) 0.77
The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor. Transfusion (2014) 0.76
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Int J Mol Sci (2016) 0.76
Long-term follow-up study on the engraftment of human hematopoietic stem cells in sheep. Exp Anim (2014) 0.75
Polyurethane scaffolds seeded with CD34(+) cells maintain early stem cells whilst also facilitating prolonged egress of haematopoietic progenitors. Sci Rep (2016) 0.75
Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells. Stem Cell Reports (2017) 0.75
Umbilical cord blood: an expandable resource. J Clin Invest (2000) 0.75
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22
Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med (1996) 4.42
CD34: structure, biology, and clinical utility. Blood (1996) 4.41
Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev (1995) 3.81
Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci U S A (1990) 3.43
Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood (1991) 3.12
Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A (1994) 3.08
Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A (1990) 2.59
The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol (1984) 2.05
A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood (1995) 1.96
Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol (1993) 1.86
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood (1995) 1.79
Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med (1993) 1.64
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood (1991) 1.64
Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A (1996) 1.55
Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol (1996) 1.54
Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med (1996) 1.53
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood (1995) 1.45
Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood (1996) 1.44
Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci U S A (1996) 1.36
A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays. Blood (1993) 1.33
Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A (1997) 1.29
Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest (1994) 1.29
Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood (1997) 1.28
Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. Blood (1995) 1.26
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A (1996) 1.24
Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivo. Blood (1997) 1.24
gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc Natl Acad Sci U S A (1995) 1.24
Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood (1996) 1.14
Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood (1995) 1.12
Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability. Proc Natl Acad Sci U S A (1992) 1.10
Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo. Blood (1996) 1.02
Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. Blood (1996) 1.02
Hematopoietic transplant potential of unrelated cord blood: critical issues. J Hematother (1996) 0.96
Differentiation of human CD34+CD38- cord blood stem cells into B cell progenitors in vitro. Exp Hematol (1997) 0.91
Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Br J Haematol (1997) 0.85
Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. Blood (1994) 0.81
Lineage commitment of CD34+ human hematopoietic progenitor cells. Exp Hematol (1996) 0.79
Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood (1999) 3.33
Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia (2007) 2.27
Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. Leukemia (2003) 1.85
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica (1997) 1.47
Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest (2001) 1.43
Changes in cardiac index and estimated systemic vascular resistance during induction of anaesthesia with thiopentone, methohexitone, propofol and etomidate. Br J Anaesth (1992) 1.40
Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo. Blood (1996) 1.39
Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia. Proc Natl Acad Sci U S A (1999) 1.35
Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood (1985) 1.28
Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci U S A (1988) 1.27
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol (2001) 1.27
Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology (2000) 1.23
Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors. J Exp Med (2002) 1.16
The Clock Drawing Test: utility for dementia detection in multiethnic elders. J Gerontol A Biol Sci Med Sci (1999) 1.04
Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors. Cancer Gene Ther (2006) 0.99
Introduction to stem cell biology in vitro. Threshold to the future. Ann N Y Acad Sci (1999) 0.97
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplant (2006) 0.96
BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia (2005) 0.95
Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny. Blood (1983) 0.95
CD44 isoforms in normal and leukemic hematopoiesis. Exp Hematol (1999) 0.89
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol (2003) 0.89
Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases. J Clin Invest (1985) 0.88
Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Br J Haematol (1997) 0.85
A prevalence study of errors in opioid prescribing in a large teaching hospital. Int J Clin Pract (2011) 0.84
Hematopoietic stem cells: inferences from in vivo assays. Stem Cells (1997) 0.84
Involvement of complement in B-cell, T-cell and monocyte/macrophage activation. Immunol Lett (1987) 0.83
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease. Cancer Immunol Immunother (2006) 0.83
Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions. Drug Metab Dispos (1997) 0.82
Enzyme-linked immunoassay to monitor the purification of, and to screen for monoclonal antibodies against, C3b receptor. Complement (1985) 0.82
Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia. Leuk Res (1998) 0.82
The biology of normal and neoplastic stem cells in CML. Leuk Lymphoma (1993) 0.80
Jenny's story: reinventing oneself through occupation and narrative configuration. Am J Occup Ther (1996) 0.80
Relative bioavailability of quinidine gluconate and quinidine sulfate in healthy volunteers. J Clin Pharmacol (1979) 0.80
BCR-ABL accelerates C2-ceramide-induced apoptosis. Oncogene (1998) 0.78
Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses (2005) 0.78
Mixed colony formation in vitro by the heterogeneous compartment of multipotential progenitors in human bone marrow. Leukemia (1993) 0.77
Functional identification of bovine mammary epithelial stem/progenitor cells. Vet Res Commun (2009) 0.76
Both cycling and noncycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G-CSF. Br J Haematol (1997) 0.76
Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia. Leukemia (2000) 0.75
Case report: A man on antiretroviral therapy with painful thighs. Malawi Med J (2013) 0.75
Maintenance of normal and abnormal hemopoietic cell populations in long-term cultures of CML and AML marrow cells. Prog Clin Biol Res (1985) 0.75
Multipotent stem cell origin of myelodysplastic syndromes. Blood (1989) 0.75
Changes in the cytokine regulation of stem cell self-renewal during ontogeny. Stem Cells (1998) 0.75
Altered immune responses during septicaemia in patients suffering from haematological malignancies. Int J Immunopathol Pharmacol (2012) 0.75
Public-private partnership: its impact upon physicians and their professional associates. Bull N Y Acad Med (1969) 0.75
[High dose therapy with transplantation of autologous peripheral hematopoietic stem cells. II. Indications and clinical results]. Acta Med Austriaca (1997) 0.75
Large cell lymphoma presenting as a coronal penile lesion. Mo Med (1989) 0.75
Tumour dislodgement to contralateral lung during double lumen tube insertion. Hosp Med (1998) 0.75
Behavior of human leukemic progenitor populations in long-term marrow culture. Haematol Blood Transfus (1985) 0.75
Effects of hematopoietic growth factors on nonhematopoietic cells. Immunol Ser (1992) 0.75
The effects of introducing artemether-lumefantrine malaria treatment and insecticide-impregnated bed nets to an elective surgical hospital. Trop Doct (2010) 0.75
Efficacy of Pasteur hepatitis B vaccine in medical students. Lancet (1986) 0.75
Stimulation of human early and late erythropoietic progenitor cells by insulin: evidence for different mechanisms. Adv Exp Med Biol (1988) 0.75
[High dose therapy with transplantation of autologous peripheral hematopoietic stem cells. I. Basic principles and clinical development]. Acta Med Austriaca (1997) 0.75
Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12. Bone Marrow Transplant (1996) 0.75
Irish (Republic) versus British (North West) orthopaedic trainees: what are the differences? Surgeon (2010) 0.75
Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Blood Cells Mol Dis (1995) 0.75
Post operative complications in a dedicated elective orthopaedic hospital: transfers requiring specialist critical care support. Ir Med J (2015) 0.75